Weizmann Institute of Science

Nobel Prize, Israel Prize laureate, Ada Yonath, dies aged 87

Professor Ada Yonath won the Nobel Prize in Chemistry in 2009 and the Israel Prize in Chemistry in 2002. She was born in Jerusalem and worked at Weizmann Institute of Science, Rehovot.

Israeli Nobel laureate Ada Yonath pictured in 2016.
ISRAEL MAKOV at the ‘Viewpoints’ book launch.

Israel Makov opens a window into six decades of collecting and championing Israeli art

ASAPH AHARONI

Climate change is stripping nutrients from food, global study with Israeli expert warns

LIVE IMAGING of ear tissue shows that blocking the Notch pathway disrupts stable cell structure, forcing green supporting cells to transform into red hair cells.

Breakthrough Israeli study finds potential path to reversing hearing loss


An AI model from Weizmann Institute can predict your future health – and help you change it

To train the model, the scientists let it study the medical records of each participant and then ask it to make minor predictions.

FROM LEFT, Dr. Lee Reicher, Prof. Eran Segal and Dr. Smadar Shilo.

Bacterial swirls inspire new ideas for swarm robotics, active matter, Israeli scientists say

“Each species has its own rhythm, its own average speed and turning frequency,” said Stevens. “And the greater the difference in these movement traits, the clearer the spatial separation became.”

 The Weizmann Institute is set to open a medical school in October of 2025.

Weizmann Institute: A legacy of discovery, innovation, and resilience

When Iranian ballistic missiles struck the heart of the Weizmann Institute, the message was loud and clear: not even peaceful scientific research is safe.

 THE FUTURISTIC particle accelerator building at the Weizmann Institute of Science in Rehovot, Israel.

A tragedy for science: Weizmann Institute mourns irreplaceable research losses from Iran attack

Last week, a ballistic missile assault from Iran severely damaged the Weizmann Institute, and life-saving scientific research was lost with no return.

A building at the campus of the Weizmann Institute of Science remains damaged following an Iranian missile strike on Sunday, in Rehovot, Israel June 19, 2025

Iran missiles severely damage Weizmann Institute labs, 'irreplaceable' samples destroyed

One of the labs destroyed by Iran was of a cancer researcher in the Faculty of Biology, whose lab team consisted of 12 scientists.

A building at the campus of the Weizmann Institute of Science remains damaged following an Iranian missile strike on Sunday, in Rehovot, Israel June 19, 2025

New study reveals the cellular network behind food tolerance and allergies

Weizmann scientists uncover why our immune system lets us eat without harm, how it tolerates food—and why it sometimes fails.

 The Weizmann Institute is set to open a medical school in October of 2025.

Israel Prize-winner develops technique to monitor hospital patients' vitals from afar

“It’s an incredibly moving and humbling experience to be part of such a distinguished group of individuals," Prof Yonina Eldar said.

 WEIZMANN INSTITUTE of Science professor and 2025 Israel Prize recipient Yonina Eldar: The goal is to solve a real-life clinical problem.

Grapevine April 17, 2025: Closing a circle

Movers and shakers in Israeli society.

 WEIZMANN INSTITUTE President Alon Chen (left) with Eric Gertler, trustee of the Zuckerman Israel Institute and the Zucker Family Foundation

New Israeli comprehensive study examines massive physiological load of childbirth

During pregnancy, the mother’s cardiovascular, respiratory, renal, gastrointestinal, skeletal, metabolic, endocrine, and immune systems are all affected by fetal demand.

 PROF. URI ALON: Over the course of three years, we examined data on Israeli Jews and Arabs, ultra-Orthodox (haredi) and Bedouin women who give birth to large children.

Weizmann ‘cellular trash’ study could help in battle against antibiotics resistance - study

The results surprised the researchers when they showed that a single peptide that is naturally made by the body can prove effective against a life-threatening condition.

 FROM LEFT, team members Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl.